Quantcast
Last updated on April 18, 2014 at 0:00 EDT

Latest Sequenom Stories

2013-10-25 08:25:13

NEW YORK, October 25, 2013 /PRNewswire/ -- According to a new market report published by Transparency Market Research "SNP Genotyping and Analysis Market (GeneChips, Taqman Allelic Discrimination, Pyrosequencing, AB SNPlex, Sequenom MassARRAY MALDI-TOF): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global SNP genotyping and analysis market was valued at USD 2,385.2 million in 2012 and is expected to grow at a CAGR of 21.8% from 2013 to...

2013-10-24 08:33:35

SAN DIEGO, Oct. 24, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the third quarter of 2013 after closing of the NASDAQ Global Market on Thursday, November 7, 2013. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm EST (2:00...

2013-10-22 08:32:06

The MaterniT21 PLUS Test Celebrates its Second Anniversary Since Launch SAN DIEGO, Oct. 22, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Center for Molecular Medicine, doing business as Sequenom Laboratories, has launched the Enhanced Sequencing Series for its MaterniT21(TM) PLUS laboratory-developed test (LDT). The MaterniT21 PLUS test...

2013-10-02 23:22:13

Reportbuyer.com just published a new market research report: Genetic Testing Market Outlook to 2017. London (PRWEB) October 02, 2013 A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing...

2013-10-01 12:30:55

DUBLIN, October 1, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/m2xz2z/molecular ) has announced the addition of the "Molecular Diagnostics in Genetic Testing" [http://www.researchandmarkets.com/research/m2xz2z/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics in genetic testing brings advanced analytical techniques to the diagnosis and treatment of...

2013-10-01 08:27:18

NEW YORK, October 1, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Investors' Reports announced new research reports highlighting Cubist Pharmaceuticals Inc. (NASDAQ: CBST), Halozyme Therapeutics, Inc. (NASDAQ: HALO), Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Galena Biopharma, Inc. (NASDAQ: GALE) and Sequenom Inc. (NASDAQ: SQNM). Today's readers may access these reports free of charge - including full...

2013-09-23 16:24:17

Jefferies LLC Engaged as Financial Advisor SAN DIEGO, Sept. 23, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that its Board of Directors has authorized a review of potential strategic alternatives for its Genetic Analysis business segment. The review will include evaluation of a full range of potential strategic alternatives for the Genetic Analysis business segment....

2013-09-18 08:28:34

SAN DIEGO, Sept. 18, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced a Certified Service Provider (CSP) program for the technical certification of selected laboratories offering research services using the Sequenom research-use-only MassARRAY(®) System. Certifications cover the major research applications of the MassARRAY System, including iPLEX(®) genotyping,...

2013-09-09 16:24:01

SAN DIEGO, Sept. 9, 2013 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Sequenom, Inc. (NASDAQ: SQNM) breached their fiduciary duties to shareholders. Sequenom provides genetic analysis solutions in the United States and internationally. (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO) Sequenom Stock Drops on Report of Cash Collection Problems On July 24, 2013, Sequenom announced the...

2013-08-29 08:25:33

Editor Note: For more information about this release, please scroll to bottom. LONDON, August 29, 2013 /PRNewswire/ -- The U.S. equity market ended higher on Wednesday, August 28, 2013. The S&P 500 advanced 0.27%, to close the day at 1,634.96. Shares of companies in the biotechnology industry also ended on a higher note, tracking gains in the broader market. The major movers included Inovio Pharmaceuticals Inc. (NYSE MKT: INO), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX),...